Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.
USANA Health Sciences, Inc. (NYSE: USNA) is a global nutrition company that develops and manufactures nutritional supplements, functional foods, personal care products, skincare, and healthy living products. This news page aggregates coverage of USANA’s announcements, giving readers a focused view of how the company communicates about its business, products, and strategic priorities.
Investors and observers can use this page to follow USANA’s updates on net sales outlooks, segment performance, and guidance, as reflected in press releases tied to events such as investor conferences and quarterly results. The company issues news on its direct selling operations, its Hiya direct-to-consumer segment, and its Rise Wellness business, including commentary on growth expectations, investments in inventory and capital expenditures, and integration initiatives.
USANA also publishes product-focused news, such as third-party certifications for its Probiotic and MagneCal D supplements, which have earned the ConsumerLab.com Seal of Approval. These items highlight the company’s emphasis on purity, potency, and scientific standards for its nutritional products. Additional stories cover partnerships, including its collaboration with the Jamaica Bobsleigh and Skeleton Federation, and community initiatives led by the USANA Foundation to address food insecurity.
Leadership and culture are recurring themes in USANA’s communications, with messages from its Executive Chairman and CEO on growth mindset, values-based leadership, and social wellness. By visiting this page regularly, readers can track how USANA presents its strategy, product quality, philanthropy, and international footprint through official news releases.
On March 17, 2021, Kevin Guest, CEO of USANA Health Sciences, shared insights on overcoming pandemic challenges through the "3Rs": resilience, recalibration, and relationships. He emphasized the importance of recognizing personal resilience developed during this time and the necessity of aligning life with core values. Guest highlighted the significance of nurturing relationships which have grown more crucial during the pandemic. His book, All the Right Reasons, aims to support those navigating these challenges, promoting kindness and harmony.
Summary not available.
Summary not available.
USANA Health Sciences reported a strong fiscal Q4 and full-year 2020 performance. Q4 net sales climbed 14.5% YoY to $310.5 million, with diluted EPS rising 32.6% to a record $1.87. For the full year, net sales reached $1.135 billion, up 7%, and diluted EPS hit $5.86, a 32.9% increase. The company provided initial 2021 guidance for net sales between $1.21 to $1.27 billion and diluted EPS of $6.00 to $6.45. Additionally, a new share repurchase authorization of $150 million was approved. The company remains optimistic about future growth despite ongoing pandemic challenges.
USANA Health Sciences CEO Kevin Guest reflects on the impact of a performance with country music star Collin Raye during the pandemic. His experience reinforces the importance of passion, hard work, and performing to succeed. Guest emphasizes that extraordinary success involves perseverance and grit, as highlighted in his book, All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony. He encourages others to pursue their passions and improve their skills, advocating for performance as a means to accountability and personal development.
USANA Health Sciences, Inc. (NYSE:USNA) will release its fourth-quarter results after the market closes on February 9, 2021. Following the earnings release, a 'Management Commentary, Results and Outlook' document will be available on the company's investor relations website. A conference call is scheduled for the next day at 11:00 a.m. ET, where analysts and institutional investors can discuss the announcement. USANA specializes in high-quality nutritional supplements, healthy foods, and personal care products sold globally.
USANA (NYSE: USNA) celebrated the end of 2020 with two prominent awards: the DSA Product Innovation award for its Oral Care product line and recognition for Jessica Reimer-Arias as one of PRNews' Top Women in PR. USANA's Oral Care line, which includes fluoride-free Whitening Toothpaste and Oral Probiotic, is distinguished for its innovative approach to oral hygiene. These accolades contribute to the company's impressive tally of over 60 awards in 2020, underscoring USANA's commitment to quality and innovation in nutritional products.
USANA, a leader in cellular nutrition, has received a seal of approval from ConsumerLab.com for its omega-3 supplement, BiOmega. This certification confirms that BiOmega meets strict criteria for quality, purity, and label accuracy, including containing 100% of the claimed amounts of omega-3 fatty acids. BiOmega is designed to support cardiovascular, immune, and joint health and is fortified with vitamin D. USANA has several other certified products by ConsumerLab.com, showcasing its commitment to high-quality nutritional supplements.
Summary not available.
USANA Kids Eat has organized a charity food pack, delivering over 3,605 bags equating to 144,200 meals to 36 schools in the Salt Lake area. This initiative aims to support families during the holiday season when school meals are unavailable. Brian Paul, president of the USANA Foundation, emphasized the importance of giving back during challenging times, while Michelle Benedict highlighted the critical need for such programs, as one in five Utah children face food insecurity. USANA Kids Eat has operated since 2013, addressing hunger and providing food security to at-risk children.